PMID- 11972099 OWN - NLM STAT- MEDLINE DCOM- 20020614 LR - 20190916 IS - 1077-4114 (Print) IS - 1077-4114 (Linking) VI - 24 IP - 4 DP - 2002 May TI - Transient erythroblastopenia of childhood: prospective study of 10 patients with special reference to viral infections. PG - 294-8 AB - PURPOSE: It has been proposed that human parvovirus B19 or human herpesvirus 6 (HHV-6) causes transient erythroblastopenia of childhood (TEC). This study was performed prospectively and accurately in a sufficiently large population to confirm or reject these suggestions, or possibly to find another causative agent for TEC. PATIENTS AND METHODS: The authors studied prospectively the causative aspects of 10 consecutive children with TEC presenting at five Swedish pediatric clinics from 1994 to 1998 using serologic assays and polymerase chain reaction assays for B19, HHV-6, cytomegalovirus, and Epstein-Barr virus (EBV). The authors also performed isolation investigations of virus from bone marrow, stools, and aspirate from the nasopharynx. RESULTS: The authors found acute EBV infection in one child. There were no other instances of IgM positivity for any viruses at presentation, but a few children did show IgG positivity to HHV-6 (n = 2), EBV (n = 1), and cytomegalovirus (n = 1). No children were positive with respect to IgG for B19. However, it could not be determined when these children had been infected, and thus, a connection to TEC cannot be proved or excluded. No child showed B19 or HHV-6 DNA in serum or bone marrow collected at presentation. Isolation of virus from bone marrow, stools, and aspirate from nasopharynx culture was negative in all children but one, who had rotavirus in stool. CONCLUSIONS: HHV-6, B19, EBV, and cytomegalovirus are not common causative agents of TEC. The authors found no proof of any single agent causing TEC. FAU - Skeppner, Gunnar AU - Skeppner G AD - Department of Pediatrics, Orebro Medical Center Hospital, Orebro, Sweden. gunnar.skeppner@telia.com FAU - Kreuger, Anders AU - Kreuger A FAU - Elinder, Goran AU - Elinder G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Pediatr Hematol Oncol JT - Journal of pediatric hematology/oncology JID - 9505928 RN - 0 (Antibodies, Viral) RN - 0 (DNA Primers) RN - 0 (DNA, Viral) RN - 0 (Immunoglobulins) SB - IM MH - Anemia/*virology MH - Antibodies, Viral/analysis MH - Bone Marrow/pathology/virology MH - Child, Preschool MH - Cytomegalovirus/genetics/immunology/isolation & purification MH - DNA Primers/chemistry MH - DNA, Viral/analysis MH - Epstein-Barr Virus Infections/virology MH - Erythroblasts/*virology MH - Female MH - Flow Cytometry MH - Herpesviridae Infections/virology MH - Herpesvirus 4, Human/genetics/immunology/isolation & purification MH - Herpesvirus 6, Human/genetics/immunology/isolation & purification MH - Humans MH - Immunoglobulins/analysis MH - Infant MH - Male MH - Parvoviridae Infections/virology MH - Parvovirus B19, Human/genetics/immunology/isolation & purification MH - Polymerase Chain Reaction MH - Prospective Studies EDAT- 2002/04/25 10:00 MHDA- 2002/06/18 10:01 CRDT- 2002/04/25 10:00 PHST- 2002/04/25 10:00 [pubmed] PHST- 2002/06/18 10:01 [medline] PHST- 2002/04/25 10:00 [entrez] AID - 10.1097/00043426-200205000-00015 [doi] PST - ppublish SO - J Pediatr Hematol Oncol. 2002 May;24(4):294-8. doi: 10.1097/00043426-200205000-00015.